Filing Details
- Accession Number:
- 0001493152-23-046151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-26 17:00:09
- Reporting Period:
- 2023-12-21
- Accepted Time:
- 2023-12-26 17:00:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1603207 | Notable Labs Ltd. | NTBL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1776703 | Fr Capital Holdings, L.p. | 2400 Market Street, Suite 237 Philadelphia PA 19103 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value Nis 0.35 Each | Disposition | 2023-12-21 | 2,867 | $2.51 | 1,034,478 | No | 4 | S | Indirect | See Footnote |
Ordinary Shares, Par Value Nis 0.35 Each | Disposition | 2023-12-22 | 45,000 | $2.41 | 989,478 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of December 26, 2023, FRCV held 403,294 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 586,184 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities.
- On December 21, 2023, FRCV sold 1,063 Ordinary Shares and FRCVIIIF sold 1,804 Ordinary shares, each at a weighted average price of $2.508 per share. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- On December 22, 2023, FRCV sold 16,657 Ordinary Shares and FRCVIIIF sold 28,343 Ordinary shares, each at a weighted average price of $2.4063 per share. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.